BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9197894)

  • 21. Inappropriate masturbation and schizophrenia.
    Brooks JO; Waikar MV
    J Clin Psychiatry; 2000 Jun; 61(6):451. PubMed ID: 10901350
    [No Abstract]   [Full Text] [Related]  

  • 22. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
    Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
    Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot medroxyprogesterone and bone density.
    Cundy T; Reid I
    BMJ; 1994 Jun; 308(6943):1567-8. PubMed ID: 8068107
    [No Abstract]   [Full Text] [Related]  

  • 24. Low-dose hormone replacement therapy for hot flashes.
    Mikhail N
    Mayo Clin Proc; 2003 Mar; 78(3):379; author reply 379. PubMed ID: 12630592
    [No Abstract]   [Full Text] [Related]  

  • 25. Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits".
    Archer DF
    South Med J; 2014 Nov; 107(11):696-7. PubMed ID: 25365436
    [No Abstract]   [Full Text] [Related]  

  • 26. 21-year-old woman with menstrual irregularity, 1 year later.
    Daley J; Delbanco TL; Hartman EE
    JAMA; 1997 Nov; 278(20):1699. PubMed ID: 9388091
    [No Abstract]   [Full Text] [Related]  

  • 27. Catamenial mononeuropathy and radiculopathy.
    Cirak B; Guven MB
    J Neurosurg; 1999 Feb; 90(2):374. PubMed ID: 9950514
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical use of leuprolide acetate depot in a group of gynecologic patients in the preoperative period].
    Russo P; Ciolli P; Atlante M; Carico E; Mancini R; Russo R; Vecchione A
    Minerva Ginecol; 1998 Nov; 50(11):499-502. PubMed ID: 9882992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of GnRH analogues on bone density in the vertebral column and the femur].
    Perrone G; Galoppi P; Critelli C; Bazzoffi R; Capri O; Barillaro F; Zichella L
    Minerva Ginecol; 1995 Oct; 47(10):461-5. PubMed ID: 8559437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMS updates its recommendations on the use of HRT.
    Brown S
    Menopause Int; 2013 Sep; 19(3):105-6. PubMed ID: 24195130
    [No Abstract]   [Full Text] [Related]  

  • 32. Depot medroxyprogesterone acetate contraceptive injections and skeletal health.
    Renner RM; Edelman AB; Kaunitz AM
    Womens Health (Lond); 2010 May; 6(3):339-42. PubMed ID: 20426597
    [No Abstract]   [Full Text] [Related]  

  • 33. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
    Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
    Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
    Segall-Gutierrez P; Agarwal R; Ge M; Lopez C; Hernandez G; Stanczyk FZ
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):199-205. PubMed ID: 23530919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonal contraception for adolescents].
    Butarelli M; Wunder D; Bodmer C; Birkhäuser M
    Ther Umsch; 2001 Sep; 58(9):534-40. PubMed ID: 11594151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
    JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
    Cromer B
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
    [No Abstract]   [Full Text] [Related]  

  • 39. Goserelin (Zoladex) in the treatment of fibroids.
    West CP; Lumsden MA; Baird DT
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():27-30. PubMed ID: 1532507
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
    Maheux R; Lemay A; Blanchet P; Friede J; Pratt X
    Hum Reprod; 1991 Apr; 6(4):500-5. PubMed ID: 1655823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.